The First Affiliated Hospital of Xinxiang Medical College
Phase
Observational
Started
2024-10-30
Last updated
2024-10-29
Condition(s) studied
Uroepithelial Carcinoma
Study summary
A cross-sectional study describing the current status of diagnosis and treatment of uroepithelial cancer in hospitals of different grades in Henan Province
Eligibility
Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria:
* Adults ≥18 years of age (at enrollment)
* Histologically confirmed uroepithelial carcinoma
* Patients with newly diagnosed or completed radical uroepithelial carcinoma in the early stages of uroepithelial cancer/advanced unresectable or with distant metastases of urothelial carcinoma
* Complete medical history information
Exclusion Criteria:
* Incomplete medical history and medical records
Primary outcome measure(s)
Describing the diagnosis and treatment patterns of patients with early versus advanced uroepithelial carcinoma in different grades of hospitals in Henan Province — up to the patients enrolled,an average of 1 year To describe the similarities and differences between the way patients with early and advanced uroepithelial cancer are diagnosed and treated in different levels of hospitals in Henan Province and the current guidelines for uroepithelial cancer.
Trial sites (11)
Facility
City
Region
Status
Kaifeng City Center Hospital
Kaifeng
Henan
Luoyang Renda Hospital
Luoyang
Henan
Nanyang City Center Hospital
Nanyang
Henan
Qingfeng County People's Hospital
Puyang
Henan
Department of Oncology
Xinxiang
Henan
Hui County People's Hospital
Xinxiang
Henan
Jun County People's Hospital
Xinxiang
Henan
Qi County People's Hospital
Xinxiang
Henan
Xinxiang Allied Hospital
Xinxiang
Henan
Xinxiang Central Hospital
Xinxiang
Henan
The First Affiliated Hospital of Zhengzhou University
Zhengzhou
Henan
More The First Affiliated Hospital of Xinxiang Medical College trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.